XML 83 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings (Loss) Per Share
 6 Months Ended
Apr. 03, 2020
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share EARNINGS (LOSS) PER SHARE
The following table sets forth the computation for basic and diluted net loss per share of common stock (in thousands, except per share data):
 
Three Months Ended
 
Six Months Ended
 
April 3, 2020
 
March 29, 2019
 
April 3, 2020
 
March 29, 2019
Numerator:
 
 
 
 
 
 
 
Net loss
$
(10,226
)
 
$
(46,204
)
 
$
(38,588
)
 
$
(69,600
)
Warrant liability gain
(8,647
)
 
—

 
(4,560
)
 
(3,862
)
Net loss attributable to common stockholders
$
(18,873
)
 
$
(46,204
)
 
$
(43,148
)
 
$
(73,462
)
Denominator:
 
 
 
 
 
 
 
Weighted average common shares outstanding-basic
66,522

 
65,531

 
66,375

 
65,404

Dilutive effect of warrants
563

 
—

 
546

 
206

Weighted average common shares outstanding-diluted
67,085

 
$
65,531

 
$
66,921

 
$
65,610

Loss per share-basic:
 
 
 
 
 
 
 
Net loss to common stockholders per share-basic:
$
(0.15
)
 
$
(0.71
)
 
$
(0.58
)
 
$
(1.06
)
Loss per share-diluted:
 
 
 
 
 
 
 
Net loss to common stockholders per share-diluted:
$
(0.28
)
 
$
(0.71
)
 
$
(0.64
)
 
$
(1.12
)

As of April 3, 2020, we had warrants outstanding which were reported as a liability on the condensed consolidated balance sheet. During the three and six months ended April 3, 2020, and the six months ended March 29, 2019, we recorded warrant liability gains of $8.6 million, $4.6 million and $3.9 million, respectively, associated with adjusting the fair value of the warrants in the condensed consolidated statements of operations primarily as a result of changes in our stock price. When calculating earnings per share, we are required to adjust for the dilutive effect of outstanding common stock equivalents, including adjustment to the numerator for the dilutive effect of contracts that must be settled in stock. During the three and six months ended April 3, 2020, and the six months ended March 29, 2019, we adjusted the numerator by the warrant gains of $8.6 million, $4.6 million and $3.9 million, respectively, and the denominator by the incremental shares of 562,567, 545,578 and 206,104, respectively, under the treasury stock method. The table above excludes the effects of 1,009,830 and 886,671 shares for the three and six months ended April 3, 2020, respectively, and 425,202 and 154,377 shares for the three and six months ended March 29, 2019, respectively, of potential shares of common stock issuable upon exercise of stock options, warrants, restricted stock and restricted stock units, as applicable, as the inclusion would be antidilutive.